Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) reported a 7.3% year-on-year (YoY) increase in its consolidated net profits to EGP 522.8 million in 2021, compared to EGP 487.4 million, including minority shareholders' rights.

The company generated revenues of EGP 3.44 billion in 2021, up 19.1% from EGP 2.89 billion in 2020, according to a bourse filing on Wednesday.

As for standalone businesses, the company's net profits jumped to EGP 483.92 million last year from EGP 422.83 million.

It is noteworthy to mention that during the first nine months (9M) of 2021, EIPICO reported consolidated net profits of EGP 358.69 million, up by 5.6% year-on-year (YoY) from EGP 339.46 million.